Influence of comorbidity and age on 1-, 2-, and 3-month postoperative mortality rates in gastrointestinal cancer patients

Annals of Surgical Oncology

Volumn 20, Issue 2, 2013, Pages 371-380

  Van Gestel, Yvette R B M ^a   Lemmens, Valery E P P ^a,b   De Hingh, Ignace H J T ^c   Steevens, Jessie ^d   Rutten, Harm J T ^c   Nieuwenhuijzen, Grard A P ^c   Van Dam, Ronald M ^e   Siersema, Peter D ^f  

^a Eindhoven Cancer Registry   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c CATHARINA HOSPITAL   (Netherlands)

^d Department of Research   (Netherlands)

^e MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^f UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CANCER PATIENT; CANCER REGISTRY; CANCER STAGING; COLON CANCER; COMORBIDITY; DIGESTIVE SYSTEM CANCER; ESOPHAGUS CANCER; FEMALE; HEART DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIAMPULLARY CANCER; RECTUM CANCER; STOMACH CANCER; SURGICAL MORTALITY; VASCULAR DISEASE;

AGE FACTORS; AGED; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; COMORBIDITY; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL NEOPLASMS; HEART DISEASES; HUMANS; LUNG DISEASES; MALE; NEOADJUVANT THERAPY; NEOPLASM STAGING; NETHERLANDS; POSTOPERATIVE PERIOD; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RISK FACTORS; SURVIVAL RATE; UNITED STATES; VASCULAR DISEASES;

EID: 84878829757     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-012-2663-1     Document Type: Article

References (49)

1. Milosavljevic T, Kostic-Milosavljevic M, Jovanovic I, Krstic M. Gastrointestinal and liver tumours and public health in Europe. Eur Rev Med Pharmacol Sci. 2010;14:259-62.
2. Piccirillo JF, Tierney RM, Costas I, Grove L, Spitznagel EL, Jr. Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA. 2004;291:2441-7.
3. Coebergh JW, Janssen-Heijnen ML, Post PN, Razenberg PP. Serious co-morbidity among unselected cancer patients newly diagnosed in the southeastern part of The Netherlands in 1993-1996. J Clin Epidemiol. 1999;52:1131-6.
4. Gonzalez EC, Ferrante JM, Van Durme DJ, Pal N, Roetzheim RG. Comorbid illness and the early detection of cancer. South Med J. 2001;94:913-20.
5. Iversen LH, Norgaard M, Jacobsen J, Laurberg S, Sorensen HT. The impact of comorbidity on survival of Danish colorectal cancer patients from 1995 to 2006-a population-based cohort study. Dis Colon Rectum. 2009;52:71-8.
6. Janssen-Heijnen ML, Houterman S, Lemmens VE, Louwman MW, Maas HA, Coebergh JW. Prognostic impact of increasing age and co-morbidity in cancer patients: a population-based approach. Crit Rev Oncol Hematol. 2005;55:231-40.
7. Lemmens VE, Janssen-Heijnen ML, Verheij CD, Houterman S, Repelaer van Driel OJ, Coebergh JW. Co-morbidity leads to altered treatment and worse survival of elderly patients with colorectal cancer. Br J Surg. 2005;92:615-23.
8. Yancik R, Wesley MN, Ries LA, Havlik RJ, Edwards BK, Yates JW. Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA. 2001;285:885-92.
9. van de Poll-Franse LV, Houterman S, Janssen-Heijnen ML, Dercksen MW, Coebergh JW, Haak HR. Less aggressive treatment and worse overall survival in cancer patients with diabetes: a large population based analysis. Int J Cancer. 2007;120:1986-92.
10. van de Schans SA, Janssen-Heijnen ML, Biesma B, Smeenk FW, van de Poll-Franse LV, Seynaeve C, et al. COPD in cancer patients: higher prevalence in the elderly, a different treatment strategy in case of primary tumours above the diaphragm, and a worse overall survival in the elderly patient. Eur J Cancer. 2007;43:2194-202.
11. Wong RK, Malthaner RA, Zuraw L, Rumble RB. Combined modality radiotherapy and chemotherapy in nonsurgical management of localized carcinoma of the esophagus: a practice guideline. Int J Radiat Oncol Biol Phys. 2003;55:930-42.
12. Gan S, Watson DI. New endoscopic and surgical treatment options for early esophageal adenocarcinoma. J Gastroenterol Hepatol. 2010;25:1478-84.
13. Frederiksen BL, Osler M, Harling H, Ladelund S, Jorgensen T. The impact of socioeconomic factors on 30-day mortality following elective colorectal cancer surgery: a nationwide study. Eur J Cancer. 2009;45:1248-56.
14. Janssen-Heijnen ML, Maas HA, Houterman S, Lemmens VE, Rutten HJ, Coebergh JW. Comorbidity in older surgical cancer patients: influence on patient care and outcome. Eur J Cancer. 2007;43:2179-93.
15. Kennedy GD, Rajamanickam V, O'Connor ES, Loconte NK, Foley EF, Leverson G, et al. Optimizing surgical care of colon cancer in the older adult population. Ann Surg. 2011;253:508-14.
16. Lemmens VE, Janssen-Heijnen ML, Houterman S, Verheij KD, Martijn H, van de Poll-Franse L, Coebergh JW. Which comorbid conditions predict complications after surgery for colorectal cancer? World J Surg. 2007;31:192-9.
17. McCulloch P, Ward J, Tekkis PP. Mortality and morbidity in gastro-oesophageal cancer surgery: initial results of ASCOT multicentre prospective cohort study. BMJ. 2003;327:1192-7.
18. Kieszak SM, Flanders WD, Kosinski AS, Shipp CC, Karp H. A comparison of the Charlson comorbidity index derived from medical record data and administrative billing data. J Clin Epidemiol. 1999;52:137-42.
19. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-83.
20. Van Duin C, Keij I. Sociaal-economische status indicator op postcodeniveau [in Dutch]. Maandstatistiek van de bevolking. 2002;50:32-5.
21. Fritz AG, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, et al. International classification of diseases for oncology. 3rd ed. Geneva: World Health Organization; 2000.
22. Mayo SC, Shore AD, Nathan H, Edil BH, Hirose K, Anders RA, et al. Refining the definition of perioperative mortality following hepatectomy using death within 90 days as the standard criterion. HPB (Oxford). 2011;13:473-82.
23. Venkat R, Puhan MA, Schulick RD, Cameron JL, Eckhauser FE, Choti MA, et al. Predicting the risk of perioperative mortality in patients undergoing pancreaticoduodenectomy: a novel scoring system. Arch Surg. 2011;146:1277-84.
24. Bryant AS, Rudemiller K, Cerfolio RJ. The 30- versus 90-day operative mortality after pulmonary resection. Ann Thorac Surg. 2010;89: 1717-22; discussion 1722-3.
25. Yancik R, Wesley MN, Ries LA, Havlik RJ, Long S, Edwards BK, et al. Comorbidity and age as predictors of risk for early mortality of male and female colon carcinoma patients: a population-based study. Cancer. 1998;82:2123-34.
26. Post PN, Hansen BE, Kil PJ, Janssen-Heijnen ML, Coebergh JW. The independent prognostic value of comorbidity among men aged <75 years with localized prostate cancer: a population-based study. BJU Int. 2001;87:821-6.
27. Houterman S, Janssen-Heijnen ML, Hendrikx AJ, van den Berg HA, Coebergh JW. Impact of comorbidity on treatment and prognosis of prostate cancer patients: a population-based study. Crit Rev Oncol Hematol. 2006;58:60-7.
28. Albertsen PC, Moore DF, Shih W, Lin Y, Li H, Lu-Yao GL. Impact of comorbidity on survival among men with localized prostate cancer. J Clin Oncol. 2011;29:1335-41.
29. Mangano DT. Perioperative cardiac morbidity. Anesthesiology. 1990;72:153-84.
30. Dawood MM, Gutpa DK, Southern J, Walia A, Atkinson JB, Eagle KA. Pathology of fatal perioperative myocardial infarction: implications regarding pathophysiology and prevention. Int J Cardiol. 1996;57:37-44.
31. Cohen MC, Aretz TH. Histological analysis of coronary artery lesions in fatal postoperative myocardial infarction. Cardiovasc Pathol. 1999;8:133-9.
32. Marrelli D, Roviello F, De Stefano A, Vuolo G, Brandi C, Lottini M, et al. Surgical treatment of gastrointestinal carcinomas in octogenarians: risk factors for complications and long-term outcome. Eur J Surg Oncol. 2000;26:371-6.
33. Cijs TM, Verhoef C, Steyerberg EW, Koppert LB, Tran TC, Wijnhoven BP, et al. Outcome of esophagectomy for cancer in elderly patients. Ann Thorac Surg. 2010;90:900-7.
34. Bosetti C, La Vecchia C, Negri E, Franceschi S. Wine and other types of alcoholic beverages and the risk of esophageal cancer. Eur J Clin Nutr. 2000;54:918-20.
35. Pultrum BB, Bosch DJ, Nijsten MW, Rodgers MG, Groen H, Slaets JP, et al. Extended esophagectomy in elderly patients with esophageal cancer: minor effect of age alone in determining the postoperative course and survival. Ann Surg Oncol. 2010;17:1572-80.
36. Damhuis RA, Meurs CJ, Dijkhuis CM, Stassen LP, Wiggers T. Hospital volume and post-operative mortality after resection for gastric cancer. Eur J Surg Oncol. 2002;28:401-5.
37. Dekker JW, van den Broek CB, Bastiaannet E, van de Geest LG, Tollenaar RA, Liefers GJ. Importance of the first postoperative year in the prognosis of elderly colorectal cancer patients. Ann Surg Oncol. 2011;18:1533-9.
38. Damhuis RA, Meurs CJ, Meijer WS. Postoperative mortality after cancer surgery in octogenarians and nonagenarians: results from a series of 5,390 patients. World J Surg Oncol. 2005;3:71.
39. Morris EJ, Taylor EF, Thomas JD, Quirke P, Finan PJ, Coleman MP, et al. Thirty-day postoperative mortality after colorectal cancer surgery in England. Gut. 2011;60:806-13.
40. Colorectal Cancer Collaborative Group. Surgery for colorectal cancer in elderly patients: a systematic review. Lancet. 2000;356:968-74.
41. Damhuis RA, Wereldsma JC, Wiggers T. The influence of age on resection rates and postoperative mortality in 6457 patients with colorectal cancer. Int J Colorectal Dis. 1996;11:45-8.
42. Fiscon V, Portale G, Migliorini G, Frigo F. Laparoscopic resection of colorectal cancer in elderly patients. Tumori. 2010;96:704-8.
43. Ramesh HS, Pope D, Gennari R, Audisio RA. Optimising surgical management of elderly cancer patients. World J Surg Oncol. 2005;3:17.
44. Audisio RA, Pope D, Ramesh HS, Gennari R, van Leeuwen BL, West C, et al. Shall we operate? Preoperative assessment in elderly cancer patients (PACE) can help. A SIOG surgical task force prospective study. Crit Rev Oncol Hematol. 2008;65:156-63.
45. Heriot AG, Tekkis PP, Smith JJ, Cohen CR, Montgomery A, Audisio RA, et al. Prediction of postoperative mortality in elderly patients with colorectal cancer. Dis Colon Rectum. 2006;49:816-24.
46. Pope D, Ramesh H, Gennari R, Corsini G, Maffezzini M, Hoekstra HJ, et al. Pre-operative assessment of cancer in the elderly (PACE): a comprehensive assessment of underlying characteristics of elderly cancer patients prior to elective surgery. Surg Oncol. 2006;15:189-97.
47. Aaldriks AA, Maartense E, le Cessie S, Giltay EJ, Verlaan HA, van der Geest LG, et al. Predictive value of geriatric assessment for patients older than 70 years, treated with chemotherapy. Crit Rev Oncol Hematol. 2010;79:205-12.
48. Lahat G, Sever R, Lubezky N, Nachmany I, Gerstenhaber F, Ben-Haim M, et al. Pancreatic cancer: surgery is a feasible therapeutic option for elderly patients. World J Surg Oncol. 2011;9:10.
49. Rutten HJ, den Dulk M, Lemmens VE, van de Velde CJ, Marijnen CA. Controversies of total mesorectal excision for rectal cancer in elderly patients. Lancet Oncol. 2008;9:494-501.